ResearcherAffiliated Hospital of Qingdao UniversityNo recent work listed

Chenjing Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3574-4352; OpenAlex author ID A5102895758. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper

Papers 2

LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression. Co-author DOI 10.3389/fcell.2021.661122 ↗
Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2/p53 signaling. Co-author DOI 10.1038/s41419-020-2595-9 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Xin Li · 2 shared papers, 2020–2021 · strength 0.25
- Paper LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression. DOI 10.3389/fcell.2021.661122 ↗
- Paper Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2/p53 s… DOI 10.1038/s41419-020-2595-9 ↗
Yunshan Wang · 2 shared papers, 2020–2021 · strength 0.25
- Paper LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression. DOI 10.3389/fcell.2021.661122 ↗
- Paper Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2/p53 s… DOI 10.1038/s41419-020-2595-9 ↗
Yu J Cao · 1 shared paper, 2021 · strength 0.14
- Paper LECT 2 Antagonizes FOXM1 Signaling via Inhibiting MET to Retard PDAC Progression. DOI 10.3389/fcell.2021.661122 ↗
Yu Cao · 1 shared paper, 2020 · strength 0.11
- Paper Holliday junction recognition protein promotes pancreatic cancer growth and metastasis via modulation of the MDM2/p53 s… DOI 10.1038/s41419-020-2595-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.